NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Nkarta, Inc.
Nkarta, Inc.
AbbVie
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Emory University
Bio-Path Holdings, Inc.